Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Maruff

Showing results (271-280 of 438) with videos related to

Pageof 44
Sort By:
Neurobiology of Aging|January 7, 2015
APOE ε4 moderates amyloid-related memory decline in preclinical Alzheimer's diseaseYen Ying Lim, Victor L Villemagne, Robert H Pietrzak, et al.
Alzheimer'S Research & Therapy|March 27, 2020
Disruption of cholinergic neurotransmission, within a cognitive challenge paradigm, is indicative of Aβ-related cognitive impairment in preclinical Alzheimer's disease after a 27-month delay intervalJessica Alber, Paul Maruff, Cláudia Y Santos, et al.
Plos One|October 3, 2015
Amyloid-Related Memory Decline in Preclinical Alzheimer's Disease Is Dependent on APOE ε4 and Is Detectable over 18-MonthsChristine Thai, Yen Ying Lim, Victor L Villemagne, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 31, 2016
Sensitivity of composite scores to amyloid burden in preclinical Alzheimer's disease: Introducing the Z-scores of Attention, Verbal fluency, and Episodic memory for Nondemented older adults composite scoreYen Ying Lim, Peter J Snyder, Robert H Pietrzak, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 8, 2016
Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer's diseaseRachel F Buckley, Paul Maruff, David Ames, et al.
The Lancet. Neurology|July 25, 2016
Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal studySamantha C Burnham, Pierrick Bourgeat, Vincent Doré, et al.
Journal of Alzheimer'S Disease : JAD|May 28, 2017
Effect of APOE Genotype on Amyloid Deposition, Brain Volume, and Memory in Cognitively Normal Older IndividualsYen Ying Lim, Robert Williamson, Simon M Laws, et al.
Neurobiology of Aging|January 15, 2015
Trajectories of memory decline in preclinical Alzheimer's disease: results from the Australian Imaging, Biomarkers and Lifestyle Flagship Study of ageingRobert H Pietrzak, Yen Ying Lim, David Ames, et al.
The Lancet. Neurology|March 13, 2013
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort studyVictor L Villemagne, Samantha Burnham, Pierrick Bourgeat, et al.
Neurology|February 16, 2022
Differential Effects of <i>APOE</i> and Modifiable Risk Factors on Hippocampal Volume Loss and Memory Decline in Aβ- and Aβ+ Older AdultsEmily Rosenich, Lisa Bransby, Nawaf Yassi, et al.
Pageof 44

Showing results (271-280 of 438) with videos related to

Sort By:
Pageof 44
Neurobiology of Aging|January 7, 2015
APOE ε4 moderates amyloid-related memory decline in preclinical Alzheimer's diseaseYen Ying Lim, Victor L Villemagne, Robert H Pietrzak, et al.
Alzheimer'S Research & Therapy|March 27, 2020
Disruption of cholinergic neurotransmission, within a cognitive challenge paradigm, is indicative of Aβ-related cognitive impairment in preclinical Alzheimer's disease after a 27-month delay intervalJessica Alber, Paul Maruff, Cláudia Y Santos, et al.
Plos One|October 3, 2015
Amyloid-Related Memory Decline in Preclinical Alzheimer's Disease Is Dependent on APOE ε4 and Is Detectable over 18-MonthsChristine Thai, Yen Ying Lim, Victor L Villemagne, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 31, 2016
Sensitivity of composite scores to amyloid burden in preclinical Alzheimer's disease: Introducing the Z-scores of Attention, Verbal fluency, and Episodic memory for Nondemented older adults composite scoreYen Ying Lim, Peter J Snyder, Robert H Pietrzak, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 8, 2016
Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer's diseaseRachel F Buckley, Paul Maruff, David Ames, et al.
The Lancet. Neurology|July 25, 2016
Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal studySamantha C Burnham, Pierrick Bourgeat, Vincent Doré, et al.
Journal of Alzheimer'S Disease : JAD|May 28, 2017
Effect of APOE Genotype on Amyloid Deposition, Brain Volume, and Memory in Cognitively Normal Older IndividualsYen Ying Lim, Robert Williamson, Simon M Laws, et al.
Neurobiology of Aging|January 15, 2015
Trajectories of memory decline in preclinical Alzheimer's disease: results from the Australian Imaging, Biomarkers and Lifestyle Flagship Study of ageingRobert H Pietrzak, Yen Ying Lim, David Ames, et al.
The Lancet. Neurology|March 13, 2013
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort studyVictor L Villemagne, Samantha Burnham, Pierrick Bourgeat, et al.
Neurology|February 16, 2022
Differential Effects of <i>APOE</i> and Modifiable Risk Factors on Hippocampal Volume Loss and Memory Decline in Aβ- and Aβ+ Older AdultsEmily Rosenich, Lisa Bransby, Nawaf Yassi, et al.
Pageof 44